BLISS GVS PHARMA LTD (BLISSGVS)

NSE: ₹456.20
BSE: ₹456.85
Stock Performance
Corporate Announcements
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

We would like to inform you that the ESOP Allotment Committee at its meeting held today i.e. June 11, 2026 has approved the allotment of 267250 equity shares of face value Re.1/- each to the eligible employees who have exercised their options under Bliss GVS Pharma Limited-Employee Stock Option Plan (Bliss GVS-ESOP 2019)

2026-06-11 17:19:46
Submission Of Draft Letter Of Offer In Relation To The Open Offer Made To The Public Shareholders Of Bliss GVS Pharma Limited Under The SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011

Please find attached a copy of the Draft Letter of Offer (DLOF) from SBI Capital Markets Limited, the Manager to the Open Offer.

2026-06-09 19:27:05
Intimation Of WHO-GMP Compliance Of Manufacturing Facility

Please find attached an intimation of WHO-GMP compliance of manufacturing facility located at Survey No. 43 & 44, Vevoor Village, Palghar (East).

2026-06-02 19:28:45
Detailed Public Statement In Relation To Open Offer Made To The Public Shareholders Of The Company

Please find attached a copy of newspaper publication regarding the Detailed Public Statement in connection with the Open Offer made to the public shareholders of the Company.

2026-06-01 18:54:53
Compliances-Reg.24(A)-Annual Secretarial Compliance

Please find enclosed herewith the Annual Secretarial Compliance Report for the year ended March 31, 2026.

2026-05-28 16:31:49
Announcement under Regulation 30 (LODR)-Change in Management

Intimation of Completion of Term of Mr. Santosh Parab (DIN: 01622988) as an Independent Director of the Company.

2026-05-25 19:03:18

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 108.99 171.32 161.33 163.82 148.96 182.65 179.59 156.00 163.36 190.23 164.68 211.54
YOY Revenue Growth % -26% 23.38% -4.42% 14.22% 36.67% 6.61% 11.32% -4.77% 9.67% 4.15% -8.3% 35.6%
Other Income 6.53 10.61 7.90 8.46 6.84 8.35 11.66 9.36 10.59 25.84 10.23 9.30
Total Income 115.52 181.93 169.23 172.28 155.80 191.00 191.25 165.36 173.96 216.07 174.91 220.84
Total Expenses + 104.61 135.86 140.71 146.43 129.65 167.11 161.48 151.01 143.39 182.61 147.11 177.04
Cost of Materials Consumed 63.17 83.56 80.60 78.50 91.10 91.41 88.18 68.79 88.85 89.96 79.38 102.28
Employee Benefit Expense 20.34 20.40 20.97 20.88 23.52 24.38 26.30 25.22 28.10 29.76 31.81 31.83
Other Expenses 21.65 30.31 25.85 38.41 27.53 32.15 31.34 39.07 30.85 47.23 27.67 38.14
Operating Profit 4.38 35.45 20.62 17.39 19.31 15.54 18.11 5.00 19.97 7.61 17.57 34.49
OPM % 4% 20.7% 12.8% 10.6% 13% 8.5% 10.1% 3.2% 12.2% 4% 10.7% 16.3%
Profit Before Tax + 10.90 46.07 28.52 -15.23 26.15 23.89 29.77 14.36 30.56 33.46 25.29 44.15
Tax Expense 3.41 12.18 7.80 -3.77 6.73 6.85 8.72 2.90 9.51 8.66 6.68 11.73
Tax % 31.3% 26.4% 27.4% - 25.7% 28.7% 29.3% 20.2% 31.1% 25.9% 26.4% 26.6%
Profit After Tax 7.50 33.89 20.72 -11.46 19.42 17.04 21.05 11.45 21.05 24.79 18.61 32.42
EPS (Basic) 0.72 3.25 1.99 -1.11 1.85 1.63 2.00 1.08 2.00 2.35 1.76 3.06

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Revenue from Operations 729.81 667.20 605.46 598.34 636.36 465.51 441.95
YOY Revenue Growth % 9.38% 10.2% 1.19% -5.97% 36.7% 5.33% -
Other Income 43.72 36.22 33.50 50.77 32.63 17.68 34.93
Total Income 773.53 703.42 638.96 649.11 668.98 483.20 476.88
Total Expenses + 637.91 609.25 527.62 533.41 545.33 392.01 321.37
Cost of Materials Consumed 360.46 339.47 305.83 293.66 350.83 215.65 216.31
Employee Benefit Expense 121.50 99.42 82.59 72.54 65.06 58.61 44.02
Other Expenses 131.64 130.09 116.23 120.74 118.16 62.14 61.04
Operating Profit 91.90 57.95 77.84 64.93 91.03 73.50 120.58
OPM % 12.6% 8.7% 12.9% 10.9% 14.3% 15.8% 27.3%
Profit Before Exceptional 135.62 94.17 111.34 115.69 123.66 91.19 121.71
Exceptional Items -2.16 0.00 -41.09 0.00 2.75 0.00 0.00
Profit Before Tax + 133.46 94.17 70.26 115.69 126.40 91.19 121.71
Tax Expense 36.59 25.20 19.61 30.21 33.74 23.69 29.38
Tax % 27.4% 26.8% 27.9% 26.1% 26.7% 26% 24.1%
Profit After Tax 96.87 68.97 50.64 85.48 92.66 67.50 92.33
EPS (Basic) 9.17 6.56 4.85 8.23 8.97 6.54 8.95

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
ASSETS
Non-Current Assets + 517.82 452.01 379.57 410.04 289.05 268.98 0.00
Property, Plant & Equipment 419.34 367.66 329.86 324.61 223.96 173.56 0.00
Capital Work in Progress 4.40 20.58 7.83 2.80 22.15 2.39 0.00
Non-Current Investments 18.69 18.69 18.69 18.26 18.26 18.30 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 0.20 0.22 0.10 0.21 0.35 0.53 0.00
Current Assets + 826.36 767.69 772.98 729.65 790.92 676.64 0.00
Inventories 110.92 81.94 89.45 74.15 90.11 83.68 0.00
Trade Receivables 457.12 428.25 399.51 399.06 408.82 348.68 0.00
Cash and Cash Equivalents 3.33 6.83 13.87 18.65 13.74 4.21 0.00
Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 1,155.19 1,058.63 988.44 937.00 851.43 755.65 0.00
Equity Share Capital 10.58 10.54 10.47 10.42 10.37 10.31 0.00
Other Equity 1,144.61 1,048.10 977.97 926.58 841.06 745.33 0.00
Non-Current Liabilities 20.40 36.51 46.80 49.34 35.71 43.87 0.00
Current Liabilities 168.59 124.55 117.31 153.36 192.83 146.11 0.00
Total Liabilities 188.99 161.06 164.11 202.69 228.53 189.97 0.00

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Cash from Operating Activities 123.16 97.21 125.92 43.81 114.05 66.97 0.00
Cash from Investing Activities -51.40 -77.73 -109.59 -12.97 -92.28 -61.62 0.00
Cash from Financing Activities -75.37 -26.71 -20.76 -26.05 -12.62 -11.67 0.00
Net Increase/Decrease in Cash -3.52 -7.23 -4.43 4.79 9.14 -6.33 0.00